Mesenchymal stromal cells
Top Cited Papers
- 1 November 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 13 (6) , 419-425
- https://doi.org/10.1097/01.moh.0000245697.54887.6f
Abstract
Purpose of review Our understanding of the biology and properties of mesenchymal stem cells or multipotent mesenchymal stromal cells has expanded dramatically over the last 3 years and is likely to have an impact on clinical practice in the near future, making a review of this topic both timely and relevant Recent findings Recommendations regarding nomenclature and the definition of mesenchymal stromal cells have been proposed, a rapidly dividing population within the mesenchymal stromal cell compartment has been better defined and the ability of these cells to exhibit characteristics of cells from a variety of lineages has been extended. The notion that tissue repair with mesenchymal stromal cells is related to transdifferentiation has been re-evaluated and, for the myocardium at least, may be due rather to a paracrine mechanism. The most dramatic developments have been in identifying some of the complex mechanisms underlying the immunosuppressive and nonimmunogenic properties of mesenchymal stromal cells which have important implications for the management of conditions like acute graft-versus-host disease. Summary Mesenchymal stromal cells are a biologically important cell population that are able to support hematopoiesis, can differentiate along mesenchymal and nonmesenchymal lineages in vitro, are capable of suppressing alloresponses and appear to be nonimmunogenic. These properties suggest emerging roles for mesenchymal stromal cells in cell therapy.Keywords
This publication has 77 references indexed in Scilit:
- Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarctionNature Medicine, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient miceBlood, 2005
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- Isolation and Characterization of Neurogenic Mesenchymal Stem Cells in Human Scalp TissueThe International Journal of Cell Cloning, 2005
- Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cellsBlood, 2005
- Dkk-1-derived Synthetic Peptides and Lithium Chloride for the Control and Recovery of Adult Stem Cells from Bone MarrowJournal of Biological Chemistry, 2005
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsPublished by Elsevier ,2003
- The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem CellsBiochemical and Biophysical Research Communications, 2001
- The Monoclonal Antibody SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin (CD105)Biochemical and Biophysical Research Communications, 1999